UCB/UCSF Joint Graduate Group in Bioengineering, MC2540, Department of Pharmaceutical Chemistry, School of Pharmacy, University of California, San Francisco, 1700 4th Street, San Francisco, CA 94158, USA.
Nucleic Acids Res. 2012 Sep 1;40(17):8773-81. doi: 10.1093/nar/gks597. Epub 2012 Jun 28.
Synthetic genetic sensors and circuits enable programmable control over the timing and conditions of gene expression. They are being increasingly incorporated into the control of complex, multigene pathways and cellular functions. Here, we propose a design strategy to genetically separate the sensing/circuitry functions from the pathway to be controlled. This separation is achieved by having the output of the circuit drive the expression of a polymerase, which then activates the pathway from polymerase-specific promoters. The sensors, circuits and polymerase are encoded together on a 'controller' plasmid. Variants of T7 RNA polymerase that reduce toxicity were constructed and used as scaffolds for the construction of four orthogonal polymerases identified via part mining that bind to unique promoter sequences. This set is highly orthogonal and induces cognate promoters by 8- to 75-fold more than off-target promoters. These orthogonal polymerases enable four independent channels linking the outputs of circuits to the control of different cellular functions. As a demonstration, we constructed a controller plasmid that integrates two inducible systems, implements an AND logic operation and toggles between metabolic pathways that change Escherichia coli green (deoxychromoviridans) and red (lycopene). The advantages of this organization are that (i) the regulation of the pathway can be changed simply by introducing a different controller plasmid, (ii) transcription is orthogonal to host machinery and (iii) the pathway genes are not transcribed in the absence of a controller and are thus more easily carried without invoking evolutionary pressure.
合成遗传传感器和电路使可编程控制基因表达的时间和条件成为可能。它们正越来越多地被整合到复杂的多基因途径和细胞功能的控制中。在这里,我们提出了一种设计策略,将传感/电路功能与要控制的途径从遗传上分离。这种分离是通过使电路的输出驱动聚合酶的表达来实现的,然后聚合酶从聚合酶特异性启动子激活途径。传感器、电路和聚合酶一起编码在一个“控制器”质粒上。构建了降低毒性的 T7 RNA 聚合酶变体,并将其用作通过部分挖掘鉴定的四个正交聚合酶的构建支架,这些聚合酶与独特的启动子序列结合。该集合具有高度的正交性,与靶标启动子相比,诱导同源启动子的倍数为 8 到 75 倍。这些正交聚合酶使四个独立的通道能够将电路的输出与不同细胞功能的控制联系起来。作为演示,我们构建了一个控制器质粒,该质粒整合了两个可诱导系统,实现了 AND 逻辑操作,并在改变大肠杆菌绿色(脱氧胆色质杆菌)和红色(番茄红素)的代谢途径之间进行切换。这种组织的优点是:(i)通过引入不同的控制器质粒可以简单地改变途径的调节,(ii)转录与宿主机制正交,(iii)在没有控制器的情况下途径基因不转录,因此更容易携带,而不会引起进化压力。